ABOUT US
ENJOSIM MEDICAL specializes in the research, development, and manufacturing of high-precision drug delivery devices. Its product portfolio includes delivery systems for biologics such as insulin, GLP-1, and growth hormone, with an annual production capacity of nearly 100 million injection pens.
The company operates a 16,000m² modern facility equipped with three fully automated MIKRON assembly lines, featuring Class 100,000 GMP-compliant cleanrooms, precision injection molding workshops, and an in-house mold manufacturing center, This supports a vertically integrated production system that covers product design, mold development, precision molding, and automated assembly.
ENJOSIM holds multiple medical device registrations and is certified under ISO 13485:2016 and MDSAP, along with a Canada Device License. To date, the company has completed three rounds of strategic financing and established long-term partnerships with numerous global biopharmaceutical leaders.
